Italy has approved Opaganib from Israel’s Redhill Biopharma to treat some 160 severe COVID-19 patients with severe respiratory problems at three hospitals in northern Italy. Phase2 tests on 131 US patients were positive and two critically ill Israeli patients are improving.
https://www.timesofisrael.com/2-israeli-covid-19-patients-improve-in-experimental-drug-trial/